OMER ▼ -9.0% - Omeros Corporation $OMER Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA 16-OCT-2026 06:20 AM ET